Skip to main content
See every side of every news story
Published loading...Updated

VedaBio Focused on Product Development with New Strategic Partnerships

SAN DIEGO – Nearly two years after emerging from stealth with more than $40 million, CRISPR-based molecular detection company VedaBio recently announced two strategic partnerships with Bay Area-based Mammoth Biosciences and Siemens Healthineers. The two partnerships, both announced in September, will help VedaBio advance its product development with the goal of building an advanced molecular […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

San Diego Business Journal broke the news in on Wednesday, October 8, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal